$CRTO
Criteo S.A. Stock $crto

$crto Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000157642722000047 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$510.6M	$541.1M
YoY Change	-5.64%	7.49%
Cost Of Revenue	$293.7M	$327.7M
YoY Change	-10.38%	10.19%
Gross Profit	$184.0M	$178.7M
YoY Change	2.98%	3.77%
Gross Profit Margin	36.04%	33.03%
Selling, General & Admin	$122.3M	$112.8M
YoY Change	8.47%	1.71%
% of Gross Profit	66.48%	63.11%
Research & Development	$34.03M	$31.70M
YoY Change	7.35%	-15.51%
% of Gross Profit	18.49%	17.74%
Depreciation & Amortization	$26.61M	$17.23M
YoY Change	54.49%	-36.31%
% of Gross Profit	14.46%	9.64%
Operating Expenses	$156.4M	$144.5M
YoY Change	8.22%	-2.64%
Operating Profit	$27.66M	$34.22M
YoY Change	-19.16%	43.77%
Interest Expense	$547.0K	$540.0K
YoY Change	1.3%	25.0%
% of Operating Profit	1.98%	1.58%
Other Income/Expense, Net	$4.000M	-$700.0K
YoY Change	-671.43%	109.58%
Pretax Income	$31.69M	$33.50M
YoY Change	-5.4%	42.75%
Income Tax	$10.41M	$10.05M
% Of Pretax Income	32.86%	30.0%
Net Earnings	$20.59M	$22.41M
YoY Change	-8.12%	44.94%
Net Earnings / Revenue	4.03%	4.14%
Basic Earnings Per Share	$0.34	$0.37
Diluted Earnings Per Share	$0.32	$0.35
COMMON SHARES
Basic Shares Outstanding	60.74M shares	60.74M shares
Diluted Shares Outstanding	63.61M shares	64.08M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$620.7M	$537.6M
YoY Change	15.45%	23.17%
Cash & Equivalents	$589.3M	$520.1M
Short-Term Investments	$31.39M	$17.59M
Other Short-Term Assets	$45.46M	$22.49M
YoY Change	102.1%	13.42%
Inventory
Prepaid Expenses	$28.35M	$14.41M
Receivables	$479.6M	$416.9M
Other Receivables	$87.27M	$86.17M
Total Short-Term Assets	$1.229B	$1.059B
YoY Change	15.98%	16.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$129.2M	$168.0M
YoY Change	-23.13%	-7.6%
Goodwill	$328.1M	$322.8M
YoY Change	1.64%	2.4%
Intangibles	$79.44M	$79.44M
YoY Change	0.0%	-0.47%
Long-Term Investments	$6.855M	$43.07M
YoY Change	-84.08%	111.4%
Other Assets	$32.15M	$13.51M
YoY Change	137.92%	-54.13%
Total Long-Term Assets	$686.5M	$723.1M
YoY Change	-5.07%	-5.68%
TOTAL ASSETS
Total Short-Term Assets	$1.229B	$1.059B
Total Long-Term Assets	$686.5M	$723.1M
Total Assets	$1.915B	$1.783B
YoY Change	7.44%	6.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$378.9M	$349.6M
YoY Change	8.38%	14.94%
Accrued Expenses	$125.2M	$116.0M
YoY Change	7.97%	-3.81%
Deferred Revenue	$1.059M	$988.0K
YoY Change	7.19%	431.18%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.481M	$2.114M
YoY Change	64.66%	-8.21%
Total Short-Term Liabilities	$612.5M	$557.1M
YoY Change	9.94%	7.75%
LONG-TERM LIABILITIES
Long-Term Debt	$354.0K	$371.0K
YoY Change	-4.58%	-33.15%
Other Long-Term Liabilities	$7.676M	$9.807M
YoY Change	-21.73%	261.22%
Total Long-Term Liabilities	$100.3M	$81.74M
YoY Change	22.71%	-38.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$612.5M	$557.1M
Total Long-Term Liabilities	$100.3M	$81.74M
Total Liabilities	$712.8M	$638.9M
YoY Change	11.57%	-1.6%
SHAREHOLDERS EQUITY
Retained Earnings	$619.6M	$510.5M
YoY Change	21.37%	13.33%
Common Stock	$742.7M	$704.2M
YoY Change	5.46%	3.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$137.3M	$87.26M
YoY Change	57.37%	9.31%
Treasury Stock Shares	5.328M shares	5.598M shares
Shareholders Equity	$1.168B	$1.110B
YoY Change
Total Liabilities & Shareholders Equity	$1.915B	$1.783B
YoY Change	7.44%	6.37%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$20.59M	$22.41M
YoY Change	-8.12%	44.94%
Depreciation, Depletion And Amortization	$26.61M	$17.23M
YoY Change	54.49%	-36.31%
Cash From Operating Activities	$74.93M	$77.36M
YoY Change	-3.14%	36.34%
INVESTING ACTIVITIES
Capital Expenditures	-$10.86M	-$13.78M
YoY Change	-21.21%	17.41%
Acquisitions	$0.00
YoY Change
Other Investing Activities	$27.78M	-$3.252M
YoY Change	-954.31%	-465.8%
Cash From Investing Activities	$16.93M	-$17.03M
YoY Change	-199.37%	57.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$8.304M	$2.856M
YoY Change	190.76%	-84.34%
Debt Paid & Issued, Net	$78.51M	$182.0K
YoY Change	43039.01%
Cash From Financing Activities	-$1.367M	-$3.416M
YoY Change	-59.98%	-81.79%
NET CHANGE
Cash From Operating Activities	$74.93M	$77.36M
Cash From Investing Activities	$16.93M	-$17.03M
Cash From Financing Activities	-$1.367M	-$3.416M
Net Change In Cash	$73.82M	$32.05M
YoY Change	130.32%	80.63%
FREE CASH FLOW
Cash From Operating Activities	$74.93M	$77.36M
Capital Expenditures	-$10.86M	-$13.78M
Free Cash Flow	$85.79M	$91.14M
YoY Change	-5.88%	33.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001576427
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-36153
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Criteo S.A.
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	581988000	USD
CY2022Q1	crto	Prepaid Income Taxes PrepaidIncomeTaxes	10131000	USD
CY2021Q4	crto	Prepaid Income Taxes PrepaidIncomeTaxes	8784000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	48700000	USD
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	I0
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	32 Rue Blanche
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Paris
CY2022Q1	dei	Entity Address Country EntityAddressCountry	FR
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75009
CY2022Q1	dei	Country Region CountryRegion	33
CY2022Q1	dei	City Area Code CityAreaCode	75
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	85 09 39
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60355304	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	589343000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	515527000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139961000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45400000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	479636000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	31387000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	50299000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1228826000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1264168000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	129164000	USD
CY2022Q1	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	72869000	USD
CY2021Q4	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	73388000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	45460000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34182000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79441000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	82627000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	328125000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	329699000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	110784000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	120257000	USD
CY2022Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	374601000	USD
CY2022Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	USD
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	5000000	USD
CY2022Q1	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	6855000	USD
CY2021Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	6436000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	32145000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	35443000	USD
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	686514000	USD
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	719423000	USD
CY2022Q1	us-gaap	Assets Assets	1915340000	USD
CY2021Q4	us-gaap	Assets Assets	1983591000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	430245000	USD
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2864000	USD
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	3059000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7450000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6641000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	612515000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	672548000	USD
CY2022Q1	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	3481000	USD
CY2021Q4	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	642000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31373000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34066000	USD
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58780000	USD
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	60236000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	93817000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	98136000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40149000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39523000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2942000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3053000	USD
CY2022Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	4638000	USD
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	5531000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	112723000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	712817000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	785271000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	354000	USD
CY2021Q4	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	360000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	84692000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93893000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7676000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9886000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	100302000	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65905394	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65905394	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65905394	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65883347	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65883347	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65883347	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	2150000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2149000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	5327644	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5632536	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	137330000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	131560000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	740515000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	731248000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-56501000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-40294000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	619641000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10051000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20587000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22406000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	691000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1044000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60738299	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60741674	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63613550	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64077409	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021Q1	us-gaap	Gross Profit GrossProfit	178698000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34027000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31697000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	88999000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	79354000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33336000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33428000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	156362000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	144479000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27662000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	34219000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4030000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31692000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33501000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10414000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	601588000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1168475000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1163131000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	34048000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	35189000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1202523000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1198320000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1915340000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1983591000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	293650000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	327667000	USD
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	32893000	USD
CY2021Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	34712000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	184024000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19218000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-36983000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1086000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-629000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18132000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-36354000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3146000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12904000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4380000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11446000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1234000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1458000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1152687000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-36354000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2151000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4930000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6760000	USD
CY2021Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1143763000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1198320000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18132000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	320000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8304000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9041000	USD
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1202523000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	280000000	USD
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	303342	shares
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	27.4
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	183571	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	21278000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2022Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	34726000	USD
CY2021Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	30017000	USD
CY2022Q1	crto	Depreciation Depletion And Amortization And Provisions For Various DepreciationDepletionAndAmortizationAndProvisionsForVarious	26611000	USD
CY2021Q1	crto	Depreciation Depletion And Amortization And Provisions For Various DepreciationDepletionAndAmortizationAndProvisionsForVarious	17225000	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-9000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3945000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9489000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7215000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2868000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4998000	USD
CY2022Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-432000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-3379000	USD
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3819000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-13000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-18926000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-23895000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-92738000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-47226000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-49672000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-10640000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	18947000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5050000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3182000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4527000	USD
CY2022Q1	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-2011000	USD
CY2021Q1	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-3114000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74930000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77362000	USD
CY2022Q1	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	10857000	USD
CY2021Q1	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	11953000	USD
CY2022Q1	crto	Increase Decrease In Accounts Payable Related To Intangible Assets Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToIntangibleAssetsPropertyPlantAndEquipment	5293000	USD
CY2021Q1	crto	Increase Decrease In Accounts Payable Related To Intangible Assets Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToIntangibleAssetsPropertyPlantAndEquipment	-1827000	USD
CY2022Q1	crto	Payments For Proceeds From Change In Other Financial Noncurrent Assets PaymentsForProceedsFromChangeInOtherFinancialNoncurrentAssets	-22489000	USD
CY2021Q1	crto	Payments For Proceeds From Change In Other Financial Noncurrent Assets PaymentsForProceedsFromChangeInOtherFinancialNoncurrentAssets	3252000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16925000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17032000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	78513000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	78513000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	182000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	271000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2074000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8304000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4930000	USD
CY2022Q1	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	6666000	USD
CY2021Q1	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	-378000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1367000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	367000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3416000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-16672000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-24865000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	73816000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32049000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515527000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	488011000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	589343000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520060000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7978000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8432000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	365000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9000000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6800000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	184024000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	178698000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2022Q1	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	216917000	USD
CY2021Q1	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	213410000	USD
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	32893000	USD
CY2021Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	34712000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34027000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31697000	USD
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	88999000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	79354000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33336000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33428000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	156362000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	144479000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27662000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	34219000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4030000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31692000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33501000	USD
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45391000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	479636000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	581988000	USD
CY2022Q1	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	72869000	USD
CY2021Q4	crto	Prepaid Other Taxes And Other Taxes Receivable PrepaidOtherTaxesAndOtherTaxesReceivable	73388000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	45460000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34182000	USD
CY2022Q1	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	6855000	USD
CY2021Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	6436000	USD
CY2022Q1	us-gaap	Marketable Securities MarketableSecurities	31387000	USD
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	55299000	USD
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	636207000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	751293000	USD
CY2022Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	374601000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	430245000	USD
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58780000	USD
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	60236000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	93817000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	98136000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40149000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39523000	USD
CY2022Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	3835000	USD
CY2021Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1002000	USD
CY2022Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	571182000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	629142000	USD
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	78782000	USD
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	137228000	USD
CY2022Q1	us-gaap	Cash Cash	510561000	USD
CY2021Q4	us-gaap	Cash Cash	378299000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	589343000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	515527000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	31385000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	55299000	USD
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	528294000	USD
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	627379000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	48658000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	479636000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	581988000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45391000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16068000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7291000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2759000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	2633000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	3306000	USD
CY2022Q1	crto	Accounts Receivable Allowance For Doubtful Accounts Currency Translation Adjustment Increase Decrease AccountsReceivableAllowanceForDoubtfulAccountsCurrencyTranslationAdjustmentIncreaseDecrease	1391000	USD
CY2021Q1	crto	Accounts Receivable Allowance For Doubtful Accounts Currency Translation Adjustment Increase Decrease AccountsReceivableAllowanceForDoubtfulAccountsCurrencyTranslationAdjustmentIncreaseDecrease	658000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	48658000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	38694000	USD
CY2022Q1	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	600000	USD
CY2021Q1	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	500000	USD
CY2022Q1	crto	Prepayments To Suppliers PrepaymentsToSuppliers	12840000	USD
CY2021Q4	crto	Prepayments To Suppliers PrepaymentsToSuppliers	9640000	USD
CY2022Q1	crto	Other Debtors OtherDebtors	4272000	USD
CY2021Q4	crto	Other Debtors OtherDebtors	9259000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	28348000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15283000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	45460000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34182000	USD
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	16214000	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	16423000	USD
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	16714000	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	17423000	USD
CY2022Q1	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	4251000	USD
CY2021Q4	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	4507000	USD
CY2022Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1911000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1088000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1059000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	82000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40149000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39523000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	9616000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	12941000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	154000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	83000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	55000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	217000	USD
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	172000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	188000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	9653000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	13053000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	6167000	USD
CY2021	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1324000	USD
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	51000	USD
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	1543000	USD
CY2021	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	468000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	5531000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	276000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	19000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	1086000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	102000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	4638000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0225
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0140
CY2022Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3858000	USD
CY2021Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	5553000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2021Q4	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNumber	6213932	shares
CY2022Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsGrantsInPeriod	726521	shares
CY2022Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsExercised	22047	shares
CY2022Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVested	184443	shares
CY2022Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsForfeitedInPeriod	363124	shares
CY2022Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsExpirationsInPeriod	0	shares
CY2022Q1	crto	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNumber	6370839	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9041000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6760000	USD
CY2022Q1	crto	Share Based Compensation Expense Employee And Non Employee ShareBasedCompensationExpenseEmployeeAndNonEmployee	9489000	USD
CY2021Q1	crto	Share Based Compensation Expense Employee And Non Employee ShareBasedCompensationExpenseEmployeeAndNonEmployee	7215000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	133000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	128000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	547000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	540000	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	530000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	417000	USD
CY2022Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	17000	USD
CY2021Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	123000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	4463000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-798000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	492000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4030000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4000000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-700000	USD
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7546000	USD
CY2021Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5053000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2868000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4998000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10414000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10051000	USD
CY2022Q1	crto	Effective Income Tax Rate Reconciliation Estimated Tax Rate Percent EffectiveIncomeTaxRateReconciliationEstimatedTaxRatePercent	0.33
CY2021Q1	crto	Effective Income Tax Rate Reconciliation Estimated Tax Rate Percent EffectiveIncomeTaxRateReconciliationEstimatedTaxRatePercent	0.30
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20587000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22406000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60738299	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60741674	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20587000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22406000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60738299	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60741674	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2591530	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2972382	shares
CY2022Q1	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	179089	shares
CY2021Q1	crto	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements Options And Bspce IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsOptionsAndBSPCE	296071	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	104632	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	67282	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63613550	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64077409	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2022Q1	crto	Loss Contingency Accrual Provision Used LossContingencyAccrualProvisionUsed	79000	USD
CY2022Q1	crto	Loss Contingency Accrual Provision Released Not Used LossContingencyAccrualProvisionReleasedNotUsed	65000	USD
CY2022Q1	crto	Loss Contingency Accrual Foreign Currency Translation Gain Loss LossContingencyAccrualForeignCurrencyTranslationGainLoss	-68000	USD
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2864000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	58840	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	332300	shares
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	3059000	USD
CY2022Q1	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	17000	USD
CY2022Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	2864000	USD
CY2022Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	3	market
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510567000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2022Q1	us-gaap	Noncurrent Assets NoncurrentAssets	208605000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	222588000	USD

Files In Submission

Name	View Source	Status
0001576427-22-000047-index-headers.html	Edgar Link	pending
0001576427-22-000047-index.html	Edgar Link	pending
0001576427-22-000047.txt	Edgar Link	pending
0001576427-22-000047-xbrl.zip	Edgar Link	pending
amendmentn2toofferletter.htm	Edgar Link	pending
amendmentn2toofferletter001.jpg	Edgar Link	pending
amendmentn2toofferletter002.jpg	Edgar Link	pending
amendmenttoexecutiveempl.htm	Edgar Link	pending
amendmenttoexecutiveempl001.jpg	Edgar Link	pending
amendmenttoexecutiveempl002.jpg	Edgar Link	pending
crto-20220331.htm	Edgar Link	pending
crto-20220331.xsd	Edgar Link	pending
crto-20220331_cal.xml	Edgar Link	unprocessable
crto-20220331_def.xml	Edgar Link	unprocessable
crto-20220331_htm.xml	Edgar Link	completed
crto-20220331_lab.xml	Edgar Link	unprocessable
crto-20220331_pre.xml	Edgar Link	unprocessable
exhibit311ceo10qq12022.htm	Edgar Link	pending
exhibit312cfo10qq12022.htm	Edgar Link	pending
exhibit321ceocfo10qq12022.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTO
Criteo S.A. Stock $crto

2022 Q1 Form 10-Q Financial Statement

#000157642722000047 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO Criteo S.A. Stock $crto

2022 Q1 Form 10-Q Financial Statement

#000157642722000047 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO
Criteo S.A. Stock $crto